MCID: STM003
MIFTS: 16

Stomach Carcinoma in Situ

Categories: Cancer diseases, Gastrointestinal diseases, Rare diseases, Genetic diseases

Aliases & Classifications for Stomach Carcinoma in Situ

MalaCards integrated aliases for Stomach Carcinoma in Situ:

Name: Stomach Carcinoma in Situ 12 15
Carcinoma in Situ of Stomach 12 73
Gastric Carcinoma in Situ 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9138
ICD10 33 D00.2
ICD9CM 35 230.2
NCIt 50 C7788
SNOMED-CT 68 189223002 92756002
UMLS 73 C0154060

Summaries for Stomach Carcinoma in Situ

MalaCards based summary : Stomach Carcinoma in Situ, also known as carcinoma in situ of stomach, is related to lip carcinoma in situ and esophagus carcinoma in situ. An important gene associated with Stomach Carcinoma in Situ is CRLF1 (Cytokine Receptor Like Factor 1). The drugs Tegafur and Oxaliplatin have been mentioned in the context of this disorder.

Related Diseases for Stomach Carcinoma in Situ

Diseases in the Familial Stomach Cancer family:

Stomach Carcinoma in Situ

Diseases related to Stomach Carcinoma in Situ via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 lip carcinoma in situ 10.3
2 esophagus carcinoma in situ 10.3

Comorbidity relations with Stomach Carcinoma in Situ via Phenotypic Disease Network (PDN):


Gastric Cancer

Symptoms & Phenotypes for Stomach Carcinoma in Situ

Drugs & Therapeutics for Stomach Carcinoma in Situ

Drugs for Stomach Carcinoma in Situ (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tegafur Approved, Investigational Phase 1 17902-23-7 5386
2
Oxaliplatin Approved, Investigational Phase 1 61825-94-3 5310940 9887054 43805 6857599
3
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
4
Levoleucovorin Approved, Investigational Phase 1 68538-85-2
5
leucovorin Approved, Nutraceutical Phase 1 58-05-9 143 6006
6
Folic Acid Approved, Nutraceutical, Vet_approved Phase 1 59-30-3 6037
7
s 1 (combination) Phase 1
8 Albumin-Bound Paclitaxel Phase 1
9 Antimetabolites Phase 1
10 Antimetabolites, Antineoplastic Phase 1
11 Antimitotic Agents Phase 1
12 Antineoplastic Agents, Phytogenic Phase 1
13 Folate Nutraceutical Phase 1
14 Vitamin B9 Nutraceutical Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers Not yet recruiting NCT03162510 Phase 1 Oxaliplatin;Albumin-Bound Paclitaxel /nab-Paclitaxel;S-1;LV

Search NIH Clinical Center for Stomach Carcinoma in Situ

Genetic Tests for Stomach Carcinoma in Situ

Anatomical Context for Stomach Carcinoma in Situ

Publications for Stomach Carcinoma in Situ

Variations for Stomach Carcinoma in Situ

Expression for Stomach Carcinoma in Situ

Search GEO for disease gene expression data for Stomach Carcinoma in Situ.

Pathways for Stomach Carcinoma in Situ

GO Terms for Stomach Carcinoma in Situ

Sources for Stomach Carcinoma in Situ

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....